Sign In
Buy GDRX
$2.67
+0.100 (+3.89%)
At Close: Jun 23, 2026
ELV vs. GDRX: Which Stock Should Value Investors Buy Now?
02:00pm, Tuesday, 26'th Jul 2022
ELV vs. GDRX: Which Stock Is the Better Value Option?
Is GoodRx's Drop a Bear Market Opportunity?
03:15pm, Wednesday, 20'th Jul 2022 The Motley Fool
The stock is down more than 85% from its 52-week high.
16 Analysts Have This to Say About GoodRx Holdings
01:30pm, Wednesday, 20'th Jul 2022 Benzinga
Over the past 3 months, 16 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding
Is GoodRx's Drop a Bear Market Opportunity?
11:15am, Wednesday, 20'th Jul 2022
The stock is down more than 85% from its 52-week high.
Is GoodRx a Growth Stock Worth Considering?
01:15pm, Friday, 15'th Jul 2022 The Motley Fool
The company's large subscriber base is impressive.
Is GoodRx a Growth Stock Worth Considering?
09:15am, Friday, 15'th Jul 2022
The company's large subscriber base is impressive.
Is Doximity a Buy?
03:15pm, Thursday, 14'th Jul 2022 The Motley Fool
The decline in share price may not be all that surprising given Doximity's egregious valuation last year.
Is This Distressed Growth Stock About to Make a Comeback?
03:37pm, Saturday, 11'th Jun 2022 The Motley Fool
Its business model is being put to the test, and it just might pass.
Is This Distressed Growth Stock About to Make a Comeback?
11:37am, Saturday, 11'th Jun 2022
Its business model is being put to the test, and it just might pass.
Netflix, Roblox stocks slammed as Goldman Sachs moves to bearish stance
02:51pm, Friday, 10'th Jun 2022 MarketWatch
"In terms of risk factors that we continue to monitor, the overall global consumer landscape remains our top focus," a Goldman Sachs analyst wrote.
Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2022
02:10pm, Friday, 10'th Jun 2022 Benzinga
Upgrades
According to Wedbush, the prior rating for SciPlay Corp (NASDAQ:SCPL) was changed from Neutral to Outperform. In the first quarter, SciPlay showed an EPS of $0.18, compared to $0.21 from the
Goldman Sachs Has 5 Well-Known Buy-Rated Stocks Under $10 With Solid Upside Potential
06:10am, Saturday, 04'th Jun 2022
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022
02:08pm, Wednesday, 01'st Jun 2022 Benzinga
Upgrades
Citigroup upgraded the previous rating for FinVolution Group (NYSE:FINV) from Neutral to Buy. FinVolution Gr earned $0.30 in the first quarter, compared to $0.31 in the year-ago quarter. The
Expert Ratings for GoodRx Holdings
01:14pm, Wednesday, 01'st Jun 2022 Benzinga
Within the last quarter, GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
3
9
0
0
Last
10 Biggest Price Target Changes For Wednesday
11:34am, Wednesday, 01'st Jun 2022 Benzinga
Keybanc cut Ambarella, Inc. (NASDAQ: AMBA) price target from $160 to $120. Ambarella shares fell 5% to $81.00 in pre-market trading.
Piper Sandler reduced Salesforce, Inc. (NYSE: CRM) price target
